Ageas, a Belgian multinational insurance company, signed a share purchase agreement on 23 February 2021 with British insurance group Aviva to acquire its 40% stake in AvivaSA, the fifth largest life insurance company and the leading private pension provider in Turkey, which is listed on Borsa Istanbul, for a total consideration of approximately GBP 122 million. Sabancı will retain its 40% stake in the company, which will allow the two long-time partners in the general insurance business to extend their collaboration to the life and pension business. The transaction is expected to close in 2021, subject to regulatory approvals.
Paksoy is pleased to announce that a team led by Stéphanie Beghe Sönmez (partner, M&A), Omer Collak (partner, Capital Markets), Nazlı Bezirci (partner, M&A), Sansal Erbacioglu (partner, tax and fiscal services) and Ökkeş Şahan (counsel, Capital Markets) advised Ageas on this transaction.
Share
Related area
Capital Markets
Insurance and Private Pensions
Tax and Fiscal Services
Related persons
You can contact us for detailed information.




Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
19 January 2026
Paksoy advises Amphenol on its acquisition of CommScope’s CCS business
Paksoy advises Amphenol Corporation on its acquisition of CommScope’s Connectivity and Cable Solutions (CCS) business.
14 January 2026
Paksoy advised Stellantis Group on the sale of BPF Pazarlama to TOFAŞ
Paksoy advised Stellantis Group on the sale of BPF Pazarlama to TOFAŞ.
13 January 2026
Paksoy advised IFC on its investment in Getmobil
Paksoy advised IFC on its investment in Getmobil.
12 January 2026
Mergermarket has ranked us #1 Legal Adviser in Turkey by deal value for 2025
Mergermarket has ranked us #1 Legal Adviser in Turkey by deal value for 2025, advising on USD 4.97 billion across 18 transactions.
7 January 2026
Paksoy advises Sanofi on the sale of a majority stake in its Lüleburgaz manufacturing facility
Paksoy advises Sanofi on the sale of a majority stake in its Lüleburgaz manufacturing facility.
5 January 2026
We are pleased to announce the promotion of Sabri Kaya to Counsel, effective as of 1 January 2026
We extend our congratulations to Sabri Kaya on his well-deserved promotion to Counsel.
